Canopy Growth Corporation - Common Shares (CGC)
1.9650
-0.0550 (-2.72%)
Canopy Growth Corp is a leading player in the cannabis industry, focusing on the production and distribution of a wide range of cannabis products
The company is engaged in cultivating and processing cannabis for both medical and recreational purposes, offering various forms such as dried flower, oils, edibles, and beverages. With a commitment to innovation, Canopy Growth invests in research and development to create high-quality products that meet consumer demands and adhere to evolving regulations. The company also emphasizes sustainability and responsible business practices, aiming to shape the future of cannabis consumption and enhance the overall experience for consumers.
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg)
CGC earnings call for the period ending December 31, 2024.
Via The Motley Fool · February 10, 2025
![](https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp)
Wondering how the US markets performed one hour before the close of the markets on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via Chartmill · February 7, 2025
![](https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp)
Discover the top movers in Friday's pre-market session and stay informed about market dynamics.
Via Chartmill · February 7, 2025
![](https://cdn.benzinga.com/files/images/story/2025/02/07/TWIC.jpeg?width=1200&height=800&fit=crop)
Cannabis news: DeSantis fights Florida's 2026 ballot, US cannabis growth slows, Tilray lands a JetBlue deal, Aurora reports stellar earnings and more.
Via Benzinga · February 7, 2025
![](https://cdn.benzinga.com/files/images/story/2025/02/07/Wall-Street-ai7-1.png?width=1200&height=800&fit=crop)
Wall Street slumped into negative territory late in the week as renewed fears over inflation and trade tariffs eroded risk appetite.
Via Benzinga · February 7, 2025
![](https://cdn.benzinga.com/files/images/story/2025/02/07/Viersen--Germany---January-9--2021-Close.jpeg?width=1200&height=800&fit=crop)
Canopy Growth Q3 sales hit C$74.76 million, surpassing estimates. Medical cannabis revenue rose 16%, while adjusted EBITDA loss improved 61% year-over-year.
Via Benzinga · February 7, 2025
![](https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp)
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Wednesday.
Via Chartmill · February 5, 2025
![](https://cdn.benzinga.com/files/images/story/2025/02/05/Portadas-Javi-Benzinga61.png?width=1200&height=800&fit=crop)
Aurora Cannabis (NASDAQACB) surged 45% after reporting record earnings, boosting CGC, TLRY, and CRON stocks.
Via Benzinga · February 5, 2025
![](https://cdn.benzinga.com/files/images/story/2025/01/29/Portadas-Javi-Benzinga62.png?width=1200&height=800&fit=crop)
Trudeau's exit leaves Canada's cannabis industry at a crossroads. Will new leadership support its growth?
Via Benzinga · January 29, 2025
![](https://cdn.benzinga.com/files/images/story/2025/01/24/TWIC.jpeg?width=1200&height=800&fit=crop)
This week in cannabis: DEA shake-up, contaminated cannabis in the Netherlands, and global market updates.
Via Benzinga · January 24, 2025
![](/next-assets/images/schema-image-default.png)
Via Benzinga · January 20, 2025
![](https://cdn.benzinga.com/files/images/story/2025/01/10/TWIC.jpeg?width=1200&height=800&fit=crop)
Cannabis news of the week: New York hits $1B cannabis sales, Ukraine registers first medical product. Updates on DoorDash, Tilray, Agrify and more.
Via Benzinga · January 10, 2025
![](https://cdn.benzinga.com/files/images/story/2025/01/08/DEA--Benzinga31-copy.jpeg?width=1200&height=800&fit=crop)
DEA judge orders agency to respond to allegations of opposing marijuana rescheduling and improper communication with opponents. Cannabis stocks declined in 2024 due to concerns about DEA review.
Via Benzinga · January 8, 2025
![](https://cdn.benzinga.com/files/images/story/2025/01/03/Ben-Caplan-Flipping-through-manuscript-2.jpeg?width=1200&height=800&fit=crop)
Surgeon general warns about alcohol's cancer risk, suggests updates to health labels. Cannabis stocks largely rise while alcohol stocks drop.
Via Benzinga · January 3, 2025
![](https://cdn.benzinga.com/files/images/story/2024/12/09/carlhart.jpeg?width=1200&height=800&fit=crop)
Dr. Carl Hart discusses hemp THC, unregulated markets, and the need for federal cannabis legalization to reduce risks and protect consumers.
Via Benzinga · December 9, 2024
![](https://cdn.benzinga.com/files/images/story/2024/12/09/elsa-olofsson-12-Zs1xIEtA-unsplash29.jpeg?width=1200&height=800&fit=crop)
Canopy USA, LLC has wrapped up its acquisition of Acreage Holdings, Inc. (CSE: ACRG.A.U, ACRG.B.U) (OTCQX: ACRHF, ACRDF), Canopy Growth Corporation's (TSX: WEED) (NASDAQCGC) U.S.-domiciled holding company said on Monday. Canopy USA, created in 2022 to streamline the Canadian cannabis giant's entry into the US market, now owns 100% of the issued and outstanding shares of Acreage. The $3.4 billion acquisition deal was first in 2019. Initially, the deal was to be undertaken should the U.S. legalize marijuana on a federal level. That deal was later restructured.
Via Benzinga · December 9, 2024
![](https://cdn.benzinga.com/files/images/story/2024/12/05/AI-Generated-Image_0.jpeg?width=1200&height=800&fit=crop)
Beyond Canada, this global cannabis company is focused on its international business, particularly in Germany, Australia, and the UK.
Via Benzinga · December 5, 2024
![](https://cdn.benzinga.com/files/images/story/2024/12/05/Curaleaf.png?width=1200&height=800&fit=crop)
In this article, we analyze Curaleaf using technical indicators, focusing on key levels and potential mid-term strategies. Let's dive in.
Via Benzinga · December 5, 2024
![](https://cdn.benzinga.com/files/images/story/2024/12/04/AI-Generated-Image_0.jpeg?width=1200&height=800&fit=crop)
Decibel, a leading Canadian pre-roll franchise, may trade closer to larger market-cap cannabis stocks, according to analyst Pablo Zuanic.
Via Benzinga · December 4, 2024
![](https://cdn.benzinga.com/files/images/story/2024/12/03/cannabis-shacking-hands-lindsayfox-and-T.jpeg?width=1200&height=800&fit=crop)
Canopy Growth Corporation (TSX: WEED) (NASDAQCGC) and Acreage Holdings, Inc. (CSE: ACRG.A.U, ACRG.B.U)(OTCQX: ACRHF, ACRDF) announced on Monday that it is anticipated that Canopy USA, LLC will complete its acquisition of Acreage on or around Dec. 9, 2024. The Canadian cannabis giant announced its plans to acquire Acreage for $3.4 billion in 2019. Initially, the deal was to be undertaken should the U.S. legalize marijuana on a federal level. That deal was later restructured. The deal outlined the plan to acquire all Class E subordinate voting shares of Acreage. This acquisition will follow the purchase of the Class D shares of Acreage, based on an agreement from October 24, 2022. After both acquisitions are completed, Canopy USA will own all shares of Acreage.
Via Benzinga · December 3, 2024
![](https://cdn.benzinga.com/files/images/story/2024/12/02/scott-graham-5fNmWej4tAA-unsplash.jpeg?width=1200&height=800&fit=crop)
Cannabis retailer Tokyo Smoke has finished its restructuring process and is no longer under financial protection, following a court's approval. The Canadian company first announced that it started restructuring its business in August, obtaining an initial order under the Companies Creditors Arrangement Act (CCAA) from the Ontario Superior Court of Justice in Canada. In Sept. the company entered a share subscription agreement with TS Investments Corp., its parent company. Under the deal, TS Investments agreed to subscribe to all of the issued and outstanding shares of Tokyo Smoke. That deal was valued at roughly $56.7 million (CA$77 million).
Via Benzinga · December 2, 2024
![](https://cdn.benzinga.com/files/images/story/2024/11/27/cannabis-sale-Dry-And-Trimmed-Marijuana-.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · November 27, 2024